Reszon ABC Combo Test – Flu A+B & COVID-19 Ag (Nasal Swab)
MDA Registration number: IVDC5790924-181335
Reszon ABC Combo Test – FLU A+B & COVID-19 Ag (Nasal Swab) is an immunochromatographic assay designed for the in vitro qualitative detection and differentiation of influenza A, B and/or SARS-CoV-2 nucleocapsid antigen in direct anterior nasal swab specimens from individuals suspected of respiratory viral infection consistent with Influenza or COVID-19 within the first seven days of symptom onset. The results obtained should not be the sole determinant for clinical decision. The test is intended for professional in vitro diagnostic use.
Platform | Immunochromatographic Assay |
Format | Cassette |
Detection | Influenza A, B and/or SARS-CoV-2 nucleocapsid antigen |
Specimen | Direct anterior nasal swab |
Sensitivity | 91.25% (Influenza A)
92.05% (Influenza B) 96.05% (COVID-19) |
Specificity | 100% (Influenza A, Influenza B and COVID-19) |
Assay Time | 20 minutes |
Shelf Life* | 24 months |
*From date of manufacture
Cat. No. |
Product Description |
Test Specimen |
Product Format |
Intended Use |
Intended Use |
Storage Temp. |
Packing Size |
---|---|---|---|---|---|---|---|
RCV-RD0301-01 |
Reszon ABC Combo Test – Flu A+B & COVID-19 Ag |
Nasal swab |
Cassette |
Influenza A, B and/or SARS-CoV-2 nucleocapsid antigen |
For Professional Use |
4-30°C |
1 T/ Kit |
RCV-RD0301-10 |
Reszon ABC Combo Test – Flu A+B & COVID-19 Ag |
Nasal swab |
Cassette |
Influenza A, B and/or SARS-CoV-2 nucleocapsid antigen |
For Professional Use |
4-30°C |
10 T/ Kit |
RCV-RD0301-25 |
Reszon ABC Combo Test – Flu A+B & COVID-19 Ag |
Nasal swab |
Cassette |
Influenza A, B and/or SARS-CoV-2 nucleocapsid antigen |
For Professional Use |
4-30°C |
25 T/ Kit |